Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

We must not steamroller patients into taking statins

The proposed QOF indicators rewarding statin therapy at the 10% risk threshold would inevitably override patient choice, argues Dr Julian Treadwell

Whilst the full content of NICE lipid guidance does make it clear that statin prescribing is only an offer, after lifestyle modification has been advised, we all know that when something becomes a QOF target it very quickly is perceived (rightly or wrongly) as a ‘must do’ unless there is a good reason not to.

The lowering of the prescribing threshold has generated some 4.5 million statin candidates, 4,448,000 of whom would not benefit from treatment over a three-year window, according to NICE figures (though 8,000 deaths, 28,000 MIs and 16,000 CVAs would be prevented).  

With chance of gain for an individual patient being so small, it is imperative that patients are not steamrollered into taking statins, which is a real danger when QOF works its magic.

NICE makes a clear statement about patient choice and have produced a decision aid to help us with that, but in the real, time limited, high-pressure world of general practice it is inevitable that the financial drive created by QOF would override this sensible advice.

The QOF consultation document does contain a recommendation to perform a QRISK assessement on new hypertensives and diabetics. This is sensible and should be quite enough.

The decision about what interventions to choose, statins or otherwise, following that assessment, should be left to the doctor and patient to decide between them without financial or tick-box pressure.

Dr Julian Treadwell is vice-chair of the RCGP overdiagnosis working group, and a sessional GP in Somerset

Rate this article  (4.15 average user rating)

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Readers' comments (2)

  • Nice says treat we jump
    My 90 yr old with a 2,days diarrhoea --taken to hospital
    Had her 3rd angiogram in 2 years all normal and a colonoscopy also normal
    Now unable to get out of bed after a few weeks there

    Unsuitable or offensive? Report this comment

  • Samuel Lewis

    NICE is right. Offering a 20mg statin is cheap and safe.

    at 10% risk or more in hypertensives and diabetics already 'medicalised' it is effective...

    well - more effective than the antihypertensive and antidiabetic agents you presumably have already prescribed ?? Why did you prescribe those agents ? How much information and choice was the patient given ?

    we are in the lottery age of NNTs in the100s where only the lucky 1% hit the jackpot each year..

    Unsuitable or offensive? Report this comment

Have your say